CEMIP and cholangiocarcinoma: A broad body of evidence also documents the association between CEMIP expression, and poor prognosis and metastasis in other types of human cancer, including lung [19,20,21], gastric [22,23,24,25], pancreatic [26], brain [27,28], breast [5,10,29,30], and papillary thyroid [31] cancers, as well as in cholangiocarcinoma [14], hepatocellular carcinoma (HCC) [32,33], laryngeal [34], and oral squamous cell carcinoma [35].